Wulf John William 4
4 · agilon health, inc. · Filed Jan 30, 2026
Research Summary
AI-generated summary of this filing
agilon health Director Wulf John William Buys 81,000 Shares
What Happened
Wulf John William, a director of agilon health, acquired 81,000 shares in an open-market purchase (transaction code P) on November 12, 2025. The filing reports a weighted-average price of $0.63 per share for a total purchase value of $50,941.
Key Details
- Transaction date: 2025-11-12 (reported on Form 4 filed 2026-01-30). Filing appears late relative to the transaction date.
- Price: weighted average $0.63; purchases ranged from $0.6251 to $0.6321 per share (see footnote F1).
- Shares acquired: 81,000; total reported cash value: $50,941.
- Shares owned after transaction: not disclosed in the provided filing details.
- Footnotes: F1 notes the weighted-average price and offers to provide per-trade breakdown on request; F2 indicates that reported holdings may include restricted stock units.
- Transaction type: Open-market purchase (code P). No option exercise, gift, or 10b5-1 plan reported.
Context
This was a purchase by a company director; purchases increase an insider’s stake but the filing does not state motivation. The Form 4 was filed on 2026-01-30 for a 2025-11-12 transaction, so investors should note the late filing when assessing disclosure timeliness.
Insider Transaction Report
Form 4
Wulf John William
Director
Transactions
- Purchase
Common Stock
[F1][F2]2025-11-12$0.63/sh+81,000$50,941→ 365,857 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.6251 to $0.6321, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
- [F2]Includes restricted stock units.
Signature
/s/ Mimi Yang, as Attorney-in-Fact|2026-01-30